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OVERVIEW — Oversight of private insurance, including health 
insurance, is primarily a state responsibility. Each state establishes 
its own laws and regulations regarding insurer activities, including 
premium increases for the insurance products within its purview. 
The authority that state regulators have to review and deny requests 
for premium changes varies from state to state, as do the amount 
of resources available to state insurance departments for reviewing 
premium changes. In some markets where insurers have proposed or 
implemented steep increases, such changes have received consider-
able attention from the press, state regulators, and policymakers. 
The Patient Protection and Affordable Care Act (PPACA) requires 
annual review of premium increases and disclosure of those 
increases determined unreasonable beginning in September 2011. 
Under PPACA, each state will conduct these reviews for individual 
and small-group health insurance unless the federal government 
concludes they do not have an effective review program and 
assumes review responsibility. As they did prior to PPACA, state 
laws govern whether rates go into effect and establish the parameters 
of regulators’ authority. This issue brief outlines specific state and 
federal roles in the rate review process and changes to rate review 
processes since PPACA was enacted.
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Individual and small-group coverage is typically purchased from insurers, which are regulated by the states, while most 
(though not all) large-group coverage is purchased from self-
funded employers, which are not subject to state regulation.1 
Nationally, about 14 million2 people were covered by individ-
ual (also called non-group) insurance and about 22 million3 
workers and dependents were covered by a small-group em-
ployer policy in 2010. Enrollees or employers on behalf of their 
employees pay a premium in exchange for a pre-determined 
set of health benefits under their health insurance. Insurers 
calculate premiums (or rates) using “actuarial estimates of the 
cost of providing coverage over a period of time to policyhold-
ers and enrollees in a health plan.”4 Policyholders may face 
premium changes each year that reflect actuarial analysis of 
the changes in the underlying costs of insurance—price and 
utilization of services, administrative costs, profit, and other 
factors.5 According to the Kaiser/HRET survey of employer-
sponsored health benefits, premiums for family coverage have 
increased between 2001 and 2011 at an average annual rate of 
7.3 percent for firms with 3 to 199 workers and 8.1 percent for 
firms with 200 or more workers.6 Data on premiums and pre-
mium trends for people with individual health insurance are 
scant, but one nationally representative survey of people with 
individual health insurance in 2010 found that 77 percent faced 
a premium increase at their last renewal, with annual increas-
es averaging 20 percent among those experiencing increases.7
A number of steep premium increases for individual and small-
group policies, as well as instances of insurer miscalculations, have 
called attention to the increasing cost of coverage, the lack of informa-
tion about what drives premium increases, and states’ authority and 
resources to oversee insurer conduct. Anthem Blue Cross of Califor-
nia’s request in February 2010 for a 39 percent increase in health in-
surance premiums in the individual market received national atten-
tion. After delaying implementation of the new rates, an independent 
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actuary hired by the state to review Anthem’s filings discovered er-
rors in its calculations, resulting in Anthem withdrawing its request 
and seeking a lower average increase of 14 percent and a maximum 
of 20 percent.8 Certainly, rate increases are not always the result of 
errors, but this case highlights the potential benefit to enrollees when 
insurers’ calculations are reviewed independently.
STATE AUTHORITY TO REVIEW AND APPROVE RATES
Regulation and licensure of health insurance is primarily a state respon-
sibility.9 Requirements for insurance carriers are generally enforced by 
a state department of insurance and the state insurance commissioner. 
Each state establishes its own laws and regulations for aspects of insur-
ers’ activities, such as financial standards, market conduct, contracts, 
consumer complaints, and premium rates for the health insurance 
products it regulates. States may have different requirements for differ-
ent market segments—individual, small-, or large-group policies—or 
for different product types such as HMOs, PPOs, or indemnity plans. 
States may define market segments differently, but most define a small 
employer as having 2 or more but not more than 50 employees and a 
large employer as having at least 51 employees.10 
One way that states exercise their regulatory authority is by requiring 
insurers to file information about rates and, in some cases, requests to 
increase rates, prior to implementing them.11 Rates are typically “filed 
as a formula that describes how to calculate a premium for each per-
son or family covered, based on information such as geographic loca-
tion, underwriting class, coverage and co-payments, age, gender, and 
number of dependents.”12 Oversight requirements for insurers’ rates 
“are used to help ensure that premium rates are adequate, not exces-
sive, reasonable in relation to the benefits provided, and not unfairly 
discriminatory.”13 As with other regulated aspects of insurer conduct, 
states vary in their requirements for notifying state regulators of rate 
changes and providing information to justify those changes. State 
regulators’ authority to review and deny requests for rate changes also 
varies, as does the amount of resources available to state insurance 
departments for reviewing rates and the information required. Most 
states require rates and supporting information to be filed with the 
state, though some require it only for HMOs or BlueCross BlueShield 
plans, or if there is a rate increase proposed. As of December 2010, ten 
states did not require such rate filings and instead require actuarial 
certification that the rates comply with state laws.14 
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States’ rate review authority falls largely into two categories: “file and 
use” and “prior approval.” In states with file and use authority, rates 
once filed with the state can go into effect on a specified date without 
state approval. In states with prior approval authority, state regula-
tors may review rate filings and approve or disapprove rates based on 
their analysis of insurers’ assumptions and calculations before they go 
into effect. In some states with prior approval authority, the rates are 
deemed approved if the state does not take action within a specified 
period, typically 30 or 60 days. Thirty-four states and the District of 
Columbia have prior approval authority over the individual or small-
group markets.15 In 13 of those states, that authority is limited to the 
individual market, the small-group market, or certain product types. 
As noted in a December 2010 report that looked in-depth at the review 
authority and practices in 10 states, a state’s statutory authority to re-
view rate increases does not provide detail about the rigor of the rate 
review process, nor does a state insurance department’s prior approval 
authority over rates necessarily preclude large rate increases from tak-
ing effect. How reviews are conducted and what actions are taken “can 
vary widely from state to state, depending on motivation, resources, 
and staff capacity.”16 A July 2011 U.S. Government Accountability Of-
fice (GAO) report observed such variation in states’ authorities, but 
also found that “not all variation in states’ practices was consistent 
with differences in state insurance departments’ authorities to review 
and approve or disapprove rate filings.”17 The report examined states’ 
oversight of private health insurance premium rates and reported the 
results of a state survey of insurance commissioners. It found varia-
tion in state authority to review rate filings and variation in practices 
such as the timing of reviews, the type of information considered, and 
opportunities for consumer input. The survey also found variation in 
the comprehensiveness of states’ reviews, for example:
Survey respondents from Texas reported that for all filings reviewed, 
all assumptions, including the experience underlying the assumptions, 
were reviewed by department actuaries for reasonableness, while re-
spondents from Pennsylvania and Missouri reported that they did not 
always perform a detailed review of information provided in rate filings. 
Respondents from Pennsylvania reported that while they compared data 
submitted by carriers in rate filings to the carriers’ previous rate filings, 
the state’s department of insurance did not have adequate capacity to 
perform a detailed review of all rate filings received from carriers. Re-
spondents from Missouri reported that they looked through the informa-
tion provided by carriers in rate filings in 2010, but that they did not have 
the authority to do a more comprehensive review.18
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REVIEW AND DISCLOSURE OF  
UNREASONABLE PREMIUM INCREASES
The Patient Protection and Affordable Care Act (PPACA, P.L. 111-
148), passed on March 23, 2010, and amended by the Health Care 
Education Reconciliation Act (P.L. 111-152), requires the Secretary of 
the Department of Health and Human Services (HHS), in conjunc-
tion with the states, to establish and carry out a process for the an-
nual review and disclosure of unreasonable health insurance pre-
mium increases.19 The final rule implementing the annual review 
and disclosure provision establishes standards and processes for 
Characteristics of an Effective State Rate Review System 
The Center for Consumer Information and Insurance Oversight (CCIIO), a division of the Centers for Medicare & 
Medicaid Services (CMS), determines a state’s rate review system to be effective if it :
• Receives sufficient data and documentation concerning rate increases to conduct an examination of the reasonable-
ness of the proposed increases.
• Considers several factors as they apply to the review: 
 {  Medical cost trend changes by major service categories
 {  Changes in utilization of services (i.e., hospital care, pharmaceuticals, office visits) by major service categories
 {  Cost-sharing changes by major service categories
 {  Changes in benefits
 {  Changes in enrollee risk profile
 {  Impact of over- or underestimate of medical trend in previous years on the current rate
 {  Reserve needs
 {  Administrative costs related to programs that improve health care quality
 {  Other administrative costs
 {  Applicable taxes and licensing or regulatory fees
 {  Medical loss ratio
 {  The issuer’s capital and surplus.
• Makes a determination of the reasonableness of the rate increase under a standard set forth in state statute or 
regulation.
• Posts either rate filings under review or preliminary justifications on their websites, or posts a link to the prelimi-
nary justifications that appear on the CMS website.
• Provides a mechanism for receiving public comments on proposed rate increases.
• Reports results of rate reviews to CMS for rate increases subject to review.
Source: “Health Insurance Rate Review: Lowering Costs for American Consumers and Businesses,” Center for Consumer Information & Insurance 
Oversight, Centers for Medicare & Medicaid Services, fact sheet, available at http://cciio.cms.gov/resources/factsheets/rate_review_fact_sheet.html.
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determining whether a premium increase is unreasonable and re-
quirements for public notification of unreasonableness; it is effective 
for rate changes scheduled on or after September 1, 2011.20 Insurers 
are required to submit justification for rates that meet or exceed the 
minimum threshold for review—10 percent in 2011—and either the 
state or CMS will determine whether the increase is unreasonable. 
In states deemed to have effective rate review programs, CMS will 
adopt the states’ assessments of the reasonableness of a submitted 
rate; in states without effective programs, the federal government 
will assess reasonableness. State laws and regulations regarding rate 
review and approval authority still apply to insurers in the state, and 
rates deemed unreasonable under the federal process may still go 
into effect depending on state law. Requirements for disclosure and 
review of unreasonable premium increases apply to individual and 
small-group health insurance plans, but do not apply to large-group 
plans, grandfathered21 plans, or insurance coverage that meets the 
definition of “excepted benefits” (for example, limited scope dental 
and vision). 
CMS: Most State’s  Rate Review Programs Ef fec tive
To determine readiness to assist with the PPACA-mandated rate 
review and disclosure provisions, CMS evaluated each state’s cur-
rent review process and determined whether it has an effective rate 
review program for individual and small-group market products. 
(See text box for characteristics of an effective rate review system.) 
Based on its review and evaluation, CMS announced that, as of Au-
gust 22, 2011:
• 42 states, the District of Columbia, and the U.S. Virgin Islands 
have effective review for all insurance markets and issuers;
• 2 states (Pennsylvania and Virginia) have effective rate review for 
the individual market and the federal government will review 
small-group rates;
• 6 states (Alabama, Arizona, Louisiana, Missouri, Montana, and 
Wyoming) and four U.S. territories (American Samoa, Guam, 
Northern Mariana Islands, and Puerto Rico) were found not to 
have effective rate review programs, and the federal government 
will review rates to determine reasonableness.
PPACA required the Secretary to award grants to states during the 
five-year period beginning with fiscal year 2010 to help states carry 
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out premium reviews and provide information to the Secretary.22 The 
law appropriated $250 million to be available for spending under the 
grants program. On August 16, 2010, HHS announced the first round 
of grants to states who applied for awards; each of the 45 states that 
applied plus the District of Columbia were awarded $1 million to 
enhance their current processes for reviewing health insurance pre-
mium increases. Five states—Alaska, Georgia, Iowa, Minnesota, and 
Wyoming—did not apply for the first round of grant funding. In 
their applications, states outlined their intended use of grant funds 
for pursuing additional legislative authority (18 states and DC), ex-
panding the scope of their current health insurance review process 
(21 states and DC), implementing a more extensive and detailed re-
view process (46 states), making more information available to the 
public (42 states and DC), and upgrading necessary technology (all 
grant recipients).23 Twenty-one states addressed changes to premium 
rate review in their 2011 legislative session and, as of July 21, 2011, 
nine states—Hawaii, Maine, New Mexico, New York, North Dakota, 
Tennessee, Utah, Vermont, and Washington—passed laws to change 
their rate review processes.24 A second round of grants to states was 
announced in February 2011.25 Those grants, totaling $109 million, 
were awarded to 28 states and the District of Columbia on Septem-
ber 20, 2011. States receiving the second-round grants have proposed 
to use the funding to introduce legislation to strengthen authority to 
review or publish rate increases, expand the scope of their review, 
bolster the information required from insurers, enhance consumer 
access to information about rate review, hire new staff, and improve 
information technology.26 
Defining and Determining  
“Unreasonable” Rate Increases
According to the regulation, the first step to determining whether rate 
increases are unreasonable is for CMS or the state to review rate in-
creases that meet or exceed specified thresholds. In the first year of 
the review process, an increase in the rate27 in the individual or small-
group market is subject to review if it is at least 10 percent more than 
the previous year’s rate. After the first year, state-specific thresholds 
will apply.28 State-specific thresholds will be published no later than 
June 1 of each year and will be effective September 1 of that year. 
For states determined to have effective rate review programs, CMS 
will adopt the states’ assessments of unreasonableness of a submitted 
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rate. A state’s final determination must include an explanation of its 
analysis and be provided to CMS within ten business days following 
its determination. For states lacking effective rate review programs, 
CMS will review submitted rate increases. It will use three tests to 
determine whether a rate increase is excessive, unjustified, or un-
fairly discriminatory and therefore unreasonable. An increase will 
be determined29:
• excessive if it causes the premium to be unreasonably high rela-
tive to the benefits of the policy. CMS will consider “whether (1) 
the rate increase would result in a projected medical loss ratio 
below the applicable federal standard; (2) one or more of the as-
sumptions is not supported by substantial evidence; and (3) the 
choice of assumptions is unreasonable.”
• unjustified “if the issuer provides data or documentation that is 
incomplete, inadequate, or otherwise does not provide a basis to 
determine whether the increase is unreasonable.”
• unfairly discriminatory “if it results in premium differences be-
tween insured people with similar risks that are not permitted 
under State law or, if there is no applicable State law, does not 
reasonably correspond to expected differences in costs.”
Justif ication for Rate Increases Subjec t to Review 
The PPACA rule establishes requirements for health insurers to sub-
mit a preliminary justification to CMS and applicable states for all 
rate increases subject to review. The health insurance issuer must 
send CMS and the state the preliminary justification (i) prior to the 
implementation of the rate increase, in states that do not require a 
proposed rate increase to be filed prior to implementation of the in-
crease, or (ii) on the date the issuer submits the proposed increase 
to the state, in states that require a proposed rate increase to be filed 
with the state prior to implementation. 
The preliminary justification has three parts. Part I, the “rate in-
crease summary,” must include:
• historical and projected claims experience, 
• trend projections related to utilization and service or unit cost, 
• claims assumptions related to benefit changes, 
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• allocation of the overall rate increase to claims and non-claims 
costs, 
• per-enrollee per-month allocation of current and projected pre-
mium, and 
• three year history of rate increases for the product associated with 
the rate increase.
Part II, the “written description justifying the rate,” is a “simple and 
brief narrative describing the data and assumptions used to develop 
the rate increase, the most significant factors causing the increase, 
and a brief description of the policies’ overall experience.” Part III 
is the “rate filing documentation,” which must be provided to CMS 
when it is reviewing the rate increase; for states with effective review 
processes CMS will accept a copy of a rate filing submitted to a state 
that included each of these elements. Part III must include:
• a description of the type of policy, benefits, renewability, general 
marketing method, and issue age limits; 
• scope and reason for the rate increase; 
• average annual premium per policy, before and after the rate 
increase; 
• past experience and any other alternative or additional data used; 
• a description of how the rate increase was determined, including 
the general description and source of each assumption used; 
• the cumulative loss ratio and a description of how it was calculated; 
• the projected future loss ratio and a description of how it was 
calculated; 
• the projected lifetime loss ratio that combines cumulative and fu-
ture experience and a description of how it was calculated; 
• the federal medical loss ratio standard in the applicable market to 
which the rate increase applies, accounting for any adjustments 
allowable under federal law; and
• if the projected future loss ratio is less than the applicable federal 
medical loss ratio, a justification for this outcome. 
The information on Parts I and II will be available for review through 
the HealthCare.gov website. Information not deemed confidential in 
Part III will be on CCIIO’s website.
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Public Release of Review Outcomes and  
Unreasonable Rate Increase Findings
The final determination of whether a rate increase is unreasonable 
will be posted on the CMS website and the insurer’s website. If CMS 
has reviewed the increase, its determination and a brief explana-
tion of its analysis will be posted within five business days. CMS 
will also provide this information to the health insurance issuer in 
cases when the increase is determined to be unreasonable. As men-
tioned above, CMS will adopt the state’s final determination in states 
deemed to have an effective review process. In states where the state 
determines that the rate increase is unreasonable, but the insurer is 
permitted to implement the increase under state law, CMS will pro-
vide the state’s final determination and explanation to the insurance 
issuer within five business days of CMS receiving the information 
from the state.
Health insurers that implement unreasonable rate increases must 
provide CMS with a “final justification” responding to CMS’s or the 
state’s determination within ten days of implementing the increase or 
receiving the final determination. Health insurers must also promi-
nently post on their website: (i) the portions of the preliminary justi-
fication posted on the CMS website; (ii) CMS’s or the state’s final de-
termination; and (iii) the issuer’s final justification. This information 
must be made available on the issuer’s website for at least three years. 
In addition, CMS will make an issuer’s final justification available on 
HealthCare.gov for three years. HHS released a preview of the pub-
licly available rate review tool for consumers on September 1, 2011.30
CONCLUSION
The PPACA provisions requiring rate review and disclosure main-
tain state responsibility for regulation of insurance and do not pro-
hibit insurers from implementing rate increases deemed excessive 
under the federal definition for non-grandfathered individual and 
small-group health insurance plans where states do not have au-
thority to disapprove rates. Rather, the law requires disclosure of 
information about premium increases and their basis to regulators. 
Regulators expect that this scrutiny, in combination with the sub-
sequent public disclosure about rates deemed excessive and other 
policy changes such as minimum medical loss ratio requirements 
for health insurers, will help to moderate premiums for consumers 
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purchasing individual or small-group insurance policies. The effec-
tiveness of the rate review and disclosure process to moderate un-
reasonable premium increases depends on adequate capacity in the 
states and in the federal government to manage the review process 
and consumer access to information, which will likely be enhanced 
by grant funding. The authority that states have to disapprove un-
reasonable rates, which is not directly affected by the PPACA re-
quirements, will also still play an important role in the moderation 
of premium increases. Although the process will not prohibit a jus-
tifiably steep rate increase from going into effect, the information 
required on the justification forms will provide valuable insight into 
the extent to which different drivers of premiums, such as price and 
use of medical services, the risk profile of covered populations, and 
administrative costs, change from year to year and contribute to pre-
mium increases. 
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